K
Kyo-diagnostics develops and provides drug sensitivity testing using patient-derived cancer stem cells (cancer spheroids) and next-generation diagnostic systems and services, aimed at achieving early social implementation of personalized cancer medicine.
Supplier IntroductionSupplier Homepage